PRESS RELEASE: DeltaRex-G for CAR-T Cell Therapy Induced Cytokine Release Syndrome

A brief administration of DeltaRex-G may be a viable treatment option for steroid-resistant CAR-T cell therapy induced cytokine release syndrome

See full article on: Frontiers in Molecular Medicine